Open AccessDisentanglement of Cape fur seals (Arctocephalus pusillus pusillus) with reversible medetomidine-midazolam-butorphanol
Author(s) -
Brett R. Gardner,
Brandon Spolander,
S. Mduduzi Seakamela,
Steven McCue,
Pieter G.H. Kotze,
Maryke Musson
Publication year - 2021
Publication title -
journal of the south african veterinary association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.535
H-Index - 31
eISSN - 2224-9435
pISSN - 1019-9128
DOI - 10.4102/jsava.v92i0.2119
Subject(s) - butorphanol , medetomidine , sedation , atipamezole , midazolam , biology , anesthesia , zoology , medicine , veterinary medicine , endocrinology , heart rate , blood pressure
Anaesthesia in pinnipeds is considered a much higher risk than in most terrestrial mammals because of their frequent proximity to water and physiological and anatomical adaptations related to diving, which also influence their anaesthesia management. Anaesthetising and immobilising entangled seals does not allow for selection of animals that are at a safe distance from the water's edge. Medetomidine-midazolam-butorphanol (MMB) sedation was trialled on eight entangled Cape fur seals (CFS) (Arctocephalus pusillus pusillus) to determine if it was safe to use on animals that entered the water post-darting. The MMB was given at an estimated dose of 0.03 mg/kg, 0.2 mg/kg and 0.2 mg/kg, respectively, via remote darting. Sedation was reversed with intramuscular atipamezole (0.15 mg/kg) and naltrexone (0.4 mg/kg) to antagonise the effects of medetomidine and butorphanol, respectively. Moderate sedation was achieved in six animals. Six of the animals entered the water after being darted. There was a single mortality and a single animal that was too lightly sedated for capture. The preliminary results indicate that MMB produces suitable sedation for disentanglement of CFS. Additionally, MMB might be suitable for application to field-based biological research.